Jacalyn H. Pierce

13.1k total citations · 5 hit papers
128 papers, 11.5k citations indexed

About

Jacalyn H. Pierce is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jacalyn H. Pierce has authored 128 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 51 papers in Oncology and 39 papers in Immunology. Recurrent topics in Jacalyn H. Pierce's work include Monoclonal and Polyclonal Antibodies Research (35 papers), HER2/EGFR in Cancer Research (24 papers) and Virus-based gene therapy research (21 papers). Jacalyn H. Pierce is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (35 papers), HER2/EGFR in Cancer Research (24 papers) and Virus-based gene therapy research (21 papers). Jacalyn H. Pierce collaborates with scholars based in United States, Italy and Israel. Jacalyn H. Pierce's co-authors include Stuart A. Aaronson, Pier Paolo Di Fiore, William E. Paul, C. Richter King, Oreste Segatto, Morris F. White, Matthias H. Kraus, Mohammad A. Heidaran, Cynthia J. Watson and Ling-Mei Wang and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jacalyn H. Pierce

128 papers receiving 11.2k citations

Hit Papers

Mast cell lines produce l... 1987 2026 2000 2013 1989 1987 1987 1989 1993 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
    1989 1.0k citations Jacalyn H. Pierce et al. profile →
  2. erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
    1987 864 citations Pier Paolo Di Fiore, Jacalyn H. Pierce et al. Science profile →
  3. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells
    1987 573 citations Pier Paolo Di Fiore, Jacalyn H. Pierce et al. profile →
  4. Isolation of a Novel Receptor cDNA Establishes the Existence of Two PDGF Receptor Genes
    1989 531 citations Mohammad A. Heidaran, Matthias H. Kraus et al. Science profile →
  5. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity.
    1993 506 citations Harald Mischak, Peter M. Blumberg et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacalyn H. Pierce United States 56 6.2k 4.0k 3.4k 1.8k 1.1k 128 11.5k
Wun-Jing Kuang United States 12 5.8k 0.9× 2.5k 0.6× 2.0k 0.6× 1.1k 0.6× 524 0.5× 12 11.7k
Andrius Kazlauskas United States 60 9.8k 1.6× 2.4k 0.6× 2.3k 0.7× 1.9k 1.0× 840 0.8× 188 15.1k
M. Shoyab United States 43 4.4k 0.7× 3.7k 0.9× 1.5k 0.5× 1.2k 0.6× 325 0.3× 125 8.0k
Olli Silvennoinen Finland 63 7.0k 1.1× 8.5k 2.1× 6.6k 1.9× 576 0.3× 728 0.7× 159 16.7k
Dennis Y. Loh United States 46 4.2k 0.7× 2.8k 0.7× 8.1k 2.4× 1.1k 0.6× 367 0.3× 77 12.2k
Ivan Gout United Kingdom 52 9.7k 1.6× 1.7k 0.4× 2.3k 0.7× 978 0.5× 925 0.9× 157 12.8k
William J. Gullick United Kingdom 60 5.1k 0.8× 6.0k 1.5× 871 0.3× 3.0k 1.6× 369 0.3× 154 10.3k
Lars Rönnstrand Sweden 54 5.9k 1.0× 2.0k 0.5× 2.0k 0.6× 506 0.3× 653 0.6× 173 10.2k
André Veillette Canada 67 5.7k 0.9× 3.5k 0.9× 9.9k 2.9× 1.8k 1.0× 505 0.5× 182 14.7k
Kenneth J. Hillan United States 36 9.0k 1.5× 4.2k 1.0× 1.4k 0.4× 1.0k 0.6× 346 0.3× 57 14.6k

Countries citing papers authored by Jacalyn H. Pierce

Since Specialization
Citations

This map shows the geographic impact of Jacalyn H. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacalyn H. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacalyn H. Pierce more than expected).

Fields of papers citing papers by Jacalyn H. Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacalyn H. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacalyn H. Pierce. The network helps show where Jacalyn H. Pierce may publish in the future.

Co-authorship network of co-authors of Jacalyn H. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Jacalyn H. Pierce. A scholar is included among the top collaborators of Jacalyn H. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacalyn H. Pierce. Jacalyn H. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly-Welch, Ann E., Helen Y. Wang, Ling-Mei Wang, et al.. (2004). Transgenic Expression of Insulin Receptor Substrate 2 in Murine B Cells Alters the Cell Density-Dependence of IgE Production In Vitro and Enhances IgE Production In Vivo. The Journal of Immunology. 172(5). 2803–2810. 14 indexed citations
2.
Soon, Lilian, Lawrence Flechner, J. Silvio Gutkind, et al.. (1999). Insulin-Like Growth Factor I Synergizes with Interleukin 4 for Hematopoietic Cell Proliferation Independent of Insulin Receptor Substrate Expression. Molecular and Cellular Biology. 19(5). 3816–3828. 46 indexed citations
3.
Wang, Ling-Mei, Angera H. Kuo, Maurizio Alimandi, et al.. (1998). ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proceedings of the National Academy of Sciences. 95(12). 6809–6814. 83 indexed citations
4.
Li, Weiqun, Yixing Jiang, Jiachang Zhang, et al.. (1998). Protein Kinase C-δ Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation. Molecular and Cellular Biology. 18(10). 5888–5898. 70 indexed citations
5.
Pinkas‐Kramarski, Ronit, Maya Shelly, Ljuba Lyass, et al.. (1998). ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network. Molecular and Cellular Biology. 18(10). 6090–6101. 113 indexed citations
6.
Stancato, Louis F., Minoru Sakatsume, Michael David, et al.. (1997). Beta Interferon and Oncostatin M Activate Raf-1 and Mitogen-Activated Protein Kinase through a JAK1-Dependent Pathway. Molecular and Cellular Biology. 17(7). 3833–3840. 98 indexed citations
7.
Yu, Jin, et al.. (1997). Oncogenic activation of the αPDGFR defines a domain that negatively regulates receptor dimerization. Oncogene. 14(2). 157–162. 14 indexed citations
8.
Li, Weiqun, Wei Li, Wei Li, et al.. (1996). Identification of Tyrosine 187 as a Protein Kinase C-δ Phosphorylation Site. Journal of Biological Chemistry. 271(42). 26404–26409. 55 indexed citations
9.
Myers, Martin G., Yitao Zhang, Timothy C. Grammer, et al.. (1996). YMXM Motifs and Signaling by an Insulin Receptor Substrate 1 Molecule without Tyrosine Phosphorylation Sites. Molecular and Cellular Biology. 16(8). 4147–4155. 84 indexed citations
10.
Myers, Martin G., Xiao‐Jian Sun, Yitao Zhang, et al.. (1994). Role of IRS-l-GRB-2 Complexes in Insulin Signaling. Molecular and Cellular Biology. 14(6). 3577–3587. 39 indexed citations
11.
Fedi, Paolo, Jacalyn H. Pierce, Pier Paolo Di Fiore, & Matthias H. Kraus. (1994). Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cϒ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Molecular and Cellular Biology. 14(1). 492–500. 20 indexed citations
12.
Mischak, Harald, et al.. (1993). ホルボールエステルによる骨髄分化はプロテインキナーゼC‐β II,‐ε,‐ζ及び‐ηではなくプロテインキナーゼC‐αと‐δにより仲介される. Journal of Biological Chemistry. 268(27). 20110–20115. 1 indexed citations
13.
Fiore, Pier Paolo Di, Kristian Helin, Matthias H. Kraus, et al.. (1992). A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2.. The EMBO Journal. 11(11). 3927–3933. 24 indexed citations
14.
15.
Segatto, Oreste, Fulvio Lonardo, D E Wexler, et al.. (1991). The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction.. Molecular and Cellular Biology. 11(6). 3191–3202. 46 indexed citations
16.
Marco, Eddi Di, et al.. (1990). Transformation of NIH 3T3 Cells by Overexpression of the Normal Coding Sequence of the Rat neu Gene. Molecular and Cellular Biology. 10(6). 3247–3252. 69 indexed citations
17.
Lonardo, Fulvio, E. Di Marco, C. Richter King, et al.. (1990). The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.. PubMed. 2(11). 992–1003. 93 indexed citations
18.
Fiore, Pier Paolo Di, Jacalyn H. Pierce, Matthias H. Kraus, et al.. (1987). erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells. Science. 237(4811). 178–182. 864 indexed citations breakdown →
19.
Holmes, Kevin L., Jacalyn H. Pierce, Wendy F. Davidson, & Herbert C. Morse. (1986). Murine hematopoietic cells with pre-B or pre-B/myeloid characteristics are generated by in vitro transformation with retroviruses containing fes, ras, abl, and src oncogenes.. The Journal of Experimental Medicine. 164(2). 443–457. 116 indexed citations
20.
Pierce, Jacalyn H. & Stuart A. Aaronson. (1982). BALB- and Harvey-murine sarcoma virus transformation of a novel lymphoid progenitor cell.. The Journal of Experimental Medicine. 156(3). 873–887. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wun-Jing Kuang Breakdown of academic impact, for papers by Andrius Kazlauskas Breakdown of academic impact, for papers by M. Shoyab Breakdown of academic impact, for papers by Olli Silvennoinen Breakdown of academic impact, for papers by Dennis Y. Loh Breakdown of academic impact, for papers by Ivan Gout Breakdown of academic impact, for papers by William J. Gullick Breakdown of academic impact, for papers by Lars Rönnstrand Breakdown of academic impact, for papers by André Veillette Breakdown of academic impact, for papers by Kenneth J. Hillan
Rankless by CCL
2026